Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.
Previous studies have demonstrated that bispecific hybrid antibodies produced by cell-cell fusion or chemically conjugated heteroaggregates can direct cytotoxic T lymphocytes to kill target cells for which they have no intrinsic specificity, a phenomenon we call effector cell retargeting (ECR). Thes...
主要な著者: | Gilliland, L, Clark, MR, Waldmann, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1988
|
類似資料
-
T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
著者:: Clark, MR, 等
出版事項: (1987) -
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.
著者:: Shalaby, MR, 等
出版事項: (1992) -
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
著者:: Freedman, J, 等
出版事項: (2017) -
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
著者:: Joshua D Freedman, 等
出版事項: (2017-06-01) -
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
著者:: Zhaoming Wang, 等
出版事項: (2021-12-01)